ECSP961987A - MATRIX METALOPROTEASE INHIBITORS (CASE RAN 4070/106) - Google Patents
MATRIX METALOPROTEASE INHIBITORS (CASE RAN 4070/106)Info
- Publication number
- ECSP961987A ECSP961987A ECSP961987A ECSP961987A EC SP961987 A ECSP961987 A EC SP961987A EC SP961987 A ECSP961987 A EC SP961987A EC SP961987 A ECSP961987 A EC SP961987A
- Authority
- EC
- Ecuador
- Prior art keywords
- cycloalkyl
- lower alkyl
- hydrogen
- heteroaralkyl
- heteroaryl
- Prior art date
Links
Abstract
Compuestos de la fórmula: (gráfico) en donde: n es 0, 1 o 2 Y es hidroxilo o XONH-donde X es hidrógeno o alquilo inferior, R1 es hidrógeno o alquilo inferior, R2 es hidrógeno, alquilo inferior, heteroalquilo, arilo, aralquilo, arilheteroalquilo, cicloalquilo, cicloalquilalquilo, heteroarilo, heteroaralquilo, heteroarilheteroalquilo, heterociclo, heterociclo-alquilo inferior, heterociclo-heteroalquilo inferior o -NR5R7, donde: R6 es hidrógeno, alquilo inferior, cicloalquilo o cicloalquil alquilo, arilo, heteroarilo y heteroaralquilo; R7 es hidrógeno alquilo inferior, cicloalquilo o cicloalquil alquilo, arilo aralquilo, heteroarilo, heteroaralquilo, C(O)R8 -C(O)NR8R9, -SO2NR8R9 -SO2NR8R9, -SO2R10, ariloxicarbonilo, o alcoxicarbonilo; o R6 y R7 junto con el átomo de nitrógeno al que están unidos representan un grupo heterociclo; donde R8 y R9 son independientemente hidrógeno, alquilo inferior, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, heteroarilo, heteroaralquilo o heteroalquilo; y R10 es alquilo inferior, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, heteroarilo, heteroaralquilo, heteroalquilo o heterociclo; o R1 y R2 junto con el tomo de carbono al que están unidos representan un grupo cicloalquilo o heterociclo; R3 es hidrógeno, alquilo inferior, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, heteroarilo, heteroaralquilo, heteroalquilo o alcoxilo inferior. R4 es hidrógeno, alquilo inferior, cicloalquilo, o cicloalquil-alquilo; o R2 y R3 junto a los carbonos a los que están unidos representan un grupo cicloalquilo, o heterociclo; o R3 y R4 junto con el carbono al que están unidos representan un grupo cicloalquilo, o y heterociclo; y R5 es alquilo inferior, cicloalquilo, cicloalquilalquilo, arilo, aralquilo, heteroarilo o heteroaralquilo; o sus sales farmacéuticamente aceptables o ésteres respectivos exhiben propiedades farmacológicas útiles, en particularpara empleo como inhibidores de metaloproteasa de matriz, partcularmente para colagenasas intersticiales.Compounds of the formula: (graph) where: n is 0, 1 or 2 Y is hydroxyl or XONH-where X is hydrogen or lower alkyl, R1 is hydrogen or lower alkyl, R2 is hydrogen, lower alkyl, heteroalkyl, aryl, aralkyl, arylheteroalkyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroaralkyl, heteroarylheteroalkyl, heterocycle, heterocyclo-lower alkyl, heterocyclo-lower heteroalkyl or -NR5R7, where: R6 is hydrogen, lower alkyl, cycloalkyl or cycloalkyl, hetero; R7 is hydrogen lower alkyl, cycloalkyl or cycloalkyl alkyl, aryl aralkyl, heteroaryl, heteroaralkyl, C (O) R8 -C (O) NR8R9, -SO2NR8R9 -SO2NR8R9, -SO2R10, aryloxycarbonyl, or alkoxycarbonyl; or R6 and R7 together with the nitrogen atom to which they are attached represent a heterocycle group; where R8 and R9 are independently hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl or heteroalkyl; and R10 is lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heteroalkyl, or heterocycle; or R1 and R2 together with the carbon atom to which they are attached represent a cycloalkyl or heterocycle group; R3 is hydrogen, lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, heteroaralkyl, heteroalkyl, or lower alkoxy. R4 is hydrogen, lower alkyl, cycloalkyl, or cycloalkyl-alkyl; or R2 and R3 together with the carbons to which they are attached represent a cycloalkyl group, or heterocycle; or R3 and R4 together with the carbon to which they are attached represent a cycloalkyl group, or and heterocycle; and R5 is lower alkyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, heteroaryl, or heteroaralkyl; or their respective pharmaceutically acceptable salts or esters exhibit useful pharmacological properties, in particular for use as matrix metalloprotease inhibitors, particularly for interstitial collagenases.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP961987 ECSP961987A (en) | 1996-12-20 | 1996-12-20 | MATRIX METALOPROTEASE INHIBITORS (CASE RAN 4070/106) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP961987 ECSP961987A (en) | 1996-12-20 | 1996-12-20 | MATRIX METALOPROTEASE INHIBITORS (CASE RAN 4070/106) |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP961987A true ECSP961987A (en) | 1998-07-23 |
Family
ID=42042714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP961987 ECSP961987A (en) | 1996-12-20 | 1996-12-20 | MATRIX METALOPROTEASE INHIBITORS (CASE RAN 4070/106) |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP961987A (en) |
-
1996
- 1996-12-20 EC ECSP961987 patent/ECSP961987A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY117574A (en) | Matrix metalloprotease inhibitors | |
AR029216A1 (en) | NON-PEPTIDIC INHIBITING COMPOUNDS OF THE VLA-4 DEPENDENT CELL UNION IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES; PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE | |
AR055878A1 (en) | CYCLOPROPANOCARBOXAMIDE DERIVATIVES | |
CO5560575A2 (en) | COMPOUNDS DERIVED FROM DIHIDRO-PTERIDINONES CHARACTERIZED FOR BEING INHIBITORS OF SPECIFIC CELL PHONE KINES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
DE69412534T2 (en) | Piperazine derivatives and their use as calmodulin inhibitors | |
BG106073A (en) | Quinoline derivatives as inhibitors of mek enzymes | |
ES2127919T3 (en) | 4-AMINO-PIRIDINES, PROCEDURE FOR ITS PREPARATION, AS WELL AS MEDICINES THAT CONTAIN THESE COMPOUNDS. | |
ATE479667T1 (en) | THIAZOLYL-BASED COMPOUNDS SUITABLE AS KINASE INHIBITORS | |
CO5130016A1 (en) | CARBOXAMIDE AND KETONE DIHYDROBENZODIOXINE DERIVATIVES | |
UY27699A1 (en) | INHIBITORS | |
FI942635A (en) | Piperazine derivatives as 5HT1A antagonists | |
ATE316967T1 (en) | CYCLIC AMIDE DERIVATIVES THAT INHIBIT CATHEPSIN K | |
ES2108027T3 (en) | NEW TRICYCLIC COMPOUNDS CONTAINING AMINO AND NITRO, USEFUL AS ACE INHIBITORS. | |
AR041882A1 (en) | IMIDAZOPIRIDINE COMPOUNDS, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR041218A1 (en) | DERIVADOS DE INDOLILO, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE OF THE COMPOUND TO PREPARE A MEDICINAL PRODUCT | |
ECSP961987A (en) | MATRIX METALOPROTEASE INHIBITORS (CASE RAN 4070/106) | |
CO5180541A1 (en) | PROTEASE INHIBITORS OF THE 1,3-DIAMINOCETONE TYPE WITH 8-14 MEMBER RING | |
CO5031336A1 (en) | FUNGICIDE BLENDS CONTAINING CARBAMATES AND AN AROMATIC DERIVATIVE | |
AR016724A1 (en) | 2-AMINOPIRIDINE COMPOUNDS CONTAINING SUBSTITUTES OF CONDENSED RINGS, PHARMACEUTICAL COMPOSITIONS, ITS USE FOR THE PREPARATION OF MEDICINES AND USEFUL COMPOUNDS AS INTERMEDIARIES | |
CA2193178A1 (en) | Matrix metalloprotease inhibitors | |
DK0481742T3 (en) | piperazine | |
ES481505A1 (en) | Aminophenyl Ether Compounds | |
AR005123A1 (en) | DERIVATIVES OF CARBOXYLIC ACIDS, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM AND USE OF SUCH DERIVATIVES | |
AR011011A1 (en) | COMPOUNDS OF 3- [PIPERIDIN-4-IL] - AND 3- [1,2,3,6-TETRAHIDROPIRIDIN-4-IL] - PIRROL [3,2-B] -PIRIDINE-5-SUBSTITUTED USEFUL AS RECEPTOR AGONISTS 5-TH (1F), PROCEDURE FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS FORMULATED WITH SUCH COMPOUNDS | |
CO4230083A1 (en) | NOVEL CARBOMATES AND UREAS AS MODIFICATIONS TO THE RESISTANCE TO MULTIPLE DRUGS |